As previously reported, BofA analyst Michael Ryskin downgraded Icon (ICLR) to Underperform from Neutral with a price target of $75, down from $195, after the company announced an internal board investigation into accounting practices and controls and noted that preliminary indications are that the company may have overstated revenues in 2023-2024 by up to 2% each fiscal year. Icon is also withdrawing the FY25 guidance and delaying Q4 results, notes the analyst, who note that there were already “significant doubts” given recent results and macro concerns and that this investigation “only compounds these issues.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- Icon downgraded to Market Perform from Outperform at Leerink
- Icon downgraded to Underperform from Neutral at BofA
- Icon downgraded to Hold from Buy at Nephron Research
- ICON Probes Accounting Practices, Delays 2025 Results and Withdraws Guidance
- Icon withdraws previously issued 2025 full year financial guidance.
